Ignite Creation Date:
2025-12-24 @ 5:45 PM
Ignite Modification Date:
2026-01-03 @ 9:30 AM
Study NCT ID:
NCT02508168
Status:
COMPLETED
Last Update Posted:
2016-10-05
First Post:
2015-07-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1 Bioavailability Study of SYR-322MET
Sponsor:
Takeda
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-04
Start Date Type:
None
Primary Completion Date:
2016-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-04
Completion Date Type:
ACTUAL
First Submit Date:
2015-07-23
First Submit QC Date:
None
Study First Post Date:
2015-07-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-10-04
Last Update Post Date:
2016-10-05
Last Update Post Date Type:
ESTIMATED